# FDA recall D-0274-2024

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2024-01-03.

## Product

Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by:Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01

## Reason for recall

Failed Impurities/Degradation Specifications

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0274-2024
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-01-03
- **Report date:** 2024-02-07
- **Termination date:** 2024-12-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0274-2024

## Citation

> AI Analytics. FDA recall D-0274-2024. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-0274-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*